Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration.

NCT02067117 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1139

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention of Influenza

Interventions

DRUG: GC FLU® Injection, GC FLU® Pre-filled Syringe Injection

Sponsor

Green Cross Corporation